









Markets
/
Stocks
/
nasdaq-lnai
/

Lunai Bioworks Ord Shs

LNAI

1.380USD

+0.130+10.40%

Close 12/08, 16:00（ET）Quotes delayed by 15 min

--Market Cap

LossP/E TTM



Lunai Bioworks Ord Shs

1.380

+0.130+10.40%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Lunai Bioworks Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---1.35M

Net income from continuing operations

--2.82M

Operating gains losses

--873.44K

Other non-cash items

---5.69M

Change in working capital

--997.43K

-Change in receivables

---6.41K

-Change in prepaid expenses

--269.26K

-Change in other current liabilities

--0.00

Cash from non-recurring investing activities

Cash from operating activities

---1.35M

Investing cash flow

Net cash flow from investment products

--544.70K

Cash from non-current investing activities

Net cash flow from investing activities

--544.70K

Financing cash flow

Cash flow from continuous financing activities

--1.34M

Net cash flow from debt Issuance/repayment

--1.34M

Net cash from non-recurrent financing activities

Net cash from financing activities

--1.34M

Net cash flow

Beginning cash balance

--92.70K

Current period cash flow changes

--532.11K

Effect of exchange rate changes

---6.84K

Ending cash balance

--624.81K

Free cash flow

---1.35M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

